- Home
- INLF vs MRKR Comparison
INLF vs MRKR Comparison
Compare INLF & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLF
- MRKR
- Stock Information
- Founded
- INLF 2016
- MRKR N/A
- Country
- INLF China
- MRKR United States
- Employees
- INLF N/A
- MRKR N/A
- Industry
- INLF Industrial Machinery/Components
- MRKR Biotechnology: Pharmaceutical Preparations
- Sector
- INLF Industrials
- MRKR Health Care
- Exchange
- INLF Nasdaq
- MRKR Nasdaq
- Market Cap
- INLF 16.2M
- MRKR 17.7M
- IPO Year
- INLF 2025
- MRKR N/A
- Fundamental
- Price
- INLF $1.09
- MRKR $1.35
- Analyst Decision
- INLF
- MRKR Strong Buy
- Analyst Count
- INLF 0
- MRKR 3
- Target Price
- INLF N/A
- MRKR $13.17
- AVG Volume (30 Days)
- INLF 148.4K
- MRKR 3.5M
- Earning Date
- INLF 01-01-0001
- MRKR 08-13-2025
- Dividend Yield
- INLF N/A
- MRKR N/A
- EPS Growth
- INLF 18.78
- MRKR N/A
- EPS
- INLF 0.13
- MRKR N/A
- Revenue
- INLF $15,796,983.00
- MRKR $5,696,123.00
- Revenue This Year
- INLF N/A
- MRKR N/A
- Revenue Next Year
- INLF N/A
- MRKR $7.16
- P/E Ratio
- INLF $8.48
- MRKR N/A
- Revenue Growth
- INLF 25.27
- MRKR 71.53
- 52 Week Low
- INLF $0.77
- MRKR $0.95
- 52 Week High
- INLF $21.00
- MRKR $5.95
- Technical
- Relative Strength Index (RSI)
- INLF N/A
- MRKR 40.86
- Support Level
- INLF N/A
- MRKR $1.41
- Resistance Level
- INLF N/A
- MRKR $1.61
- Average True Range (ATR)
- INLF 0.00
- MRKR 0.31
- MACD
- INLF 0.00
- MRKR -0.04
- Stochastic Oscillator
- INLF 0.00
- MRKR 2.15
About INLF INLIF LIMITED Ordinary Shares
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.